Capillary tube leukocyte adherence inhibition: An assay for cell-mediated immunity in cancer patients
- 15 March 1976
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 17 (3) , 338-341
- https://doi.org/10.1002/ijc.2910170309
Abstract
The leukocyte adherence inhibition (LAI) assay has been modified and automated in order to facilitate its clinical application. This new assay‐the capillary tube LAI test‐correlated with delayed cutaneous hypersensitivity using streptokinase‐streptodornase antigen in 83% of the cases. When tested with a 3 m KCI lung carcinoma antigen, lung carcinoma patients' leukocytes were more frequently inhibited (55%) than those of controls (normals 6%, other tumors 20%).This publication has 10 references indexed in Scilit:
- Inhibition of human leukocyte migration in agarose by KCl extracts of carcinoma of the lungInternational Journal of Cancer, 1975
- Cell‐mediated cytotoxicity to human pulmonary neoplasmsInternational Journal of Cancer, 1975
- Association of Anergy with an Immunosuppressive Peptide Fraction in the Serum of Patients with CancerNew England Journal of Medicine, 1974
- Antigen-mediated macrophage adherence inhibitionCellular Immunology, 1974
- Specific Immunodiagnosis of Hepatocellular Carcinoma by Leucocyte Adherence InhibitionBMJ, 1974
- Blocking and unblocking of cell-mediated anti-tumor immunity in mice, as detected by the leucocyte adherence inhibition testCellular Immunology, 1974
- A leukocyte adherence inhibition test for cell-mediated immunityJournal of Molecular Medicine, 1973
- Leukocyte adherence inhibition: A simple test for cell‐mediated tumour immunity and serum blocking factorsInternational Journal of Cancer, 1972
- Salt Extraction of Soluble HL-A AntigensScience, 1971